Standard BioTools Inc.
Symbol: LAB
NASDAQ
2.41
USDMarktpreis heute
-2.5738
P/E-Verhältnis
-0.0737
PEG-Verhältnis
923.15M
MRK Kapital
- 0.00%
DIV Rendite
Standard BioTools Inc. (LAB) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 114.9 | 165.8 | 28.5 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 63.2 | 84.5 | 0 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 19.7 | 17.3 | 18.3 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 20.5 | 21.5 | 20.8 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 3.1 | 4.3 | 4.5 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 158.2 | 208.8 | 72.1 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 54.9 | 59.5 | 65.2 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 106.3 | 106.3 | 106.4 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 1.4 | 12.6 | 27.9 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 107.7 | 118.9 | 134.3 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0.8 | 1 | 1 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | -1 | -1 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 1.5 | 3.1 | 3.7 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 164.9 | 181.5 | 203.1 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 323.1 | 390.3 | 275.2 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 9.2 | 7.9 | 10.6 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 63.9 | 5.8 | 9.9 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 1.2 | 1.2 | 1.4 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 4 | 96.9 | 101.8 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | 14.3 | 18.2 | 24.1 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 20.6 | 15.3 | 13.6 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 50.5 | 428.3 | 131.1 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 30.4 | 37.8 | 40.6 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 159.9 | 471.8 | 180.6 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 311.3 | 311.3 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -1000.8 | -926.1 | -736 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -2.2 | -1.9 | -0.9 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 854.8 | 535.2 | 831.4 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 163.2 | -81.5 | 94.6 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 323.1 | 390.3 | 275.2 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 163.2 | -81.5 | 94.6 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 64 | 84.5 | 1 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 98.2 | 102.7 | 111.6 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 46.5 | 21.3 | 83.2 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -74.7 | -190.1 | -59.2 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 15.2 | 15 | 15.6 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 6.3 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 13.1 | 14.9 | 16.1 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 1.8 | -15.5 | -19.9 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | -3 | 1.1 | 6.7 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -4.9 | -8.5 | -4.8 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 1.6 | -2.8 | 1.3 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 8.1 | -5.3 | -23.2 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -5 | 86.3 | 3.4 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2.8 | -3.8 | -13.3 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 84.3 | 0 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -94.9 | -137.3 | 0 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 118 | 53 | 0 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -84.3 | 1.3 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 20.2 | -88.1 | -11.9 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -2.1 | -6.8 | -0.5 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.8 | 225 | 1.5 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -5.4 | -0.6 | -1.8 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -0.3 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -0.1 | 13.2 | 17.1 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -6.8 | 230.8 | 16 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -0.4 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -29.6 | 52.9 | -40.1 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 51.7 | 82.3 | 29.5 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 81.3 | 29.5 | 69.5 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -43.3 | -89.4 | -44.1 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -2.8 | -3.8 | -13.3 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -46.1 | -93.2 | -57.3 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 106.3 | 97.9 | 130.6 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 55.9 | 60.9 | 61.2 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 50.5 | 37.1 | 69.4 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 7 | -12.3 | 7.6 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 113.5 | 153.3 | 136.8 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 169.4 | 214.2 | 198 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 4.3 | 0.3 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 4.6 | 4.3 | 3.8 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -11.2 | -76.7 | 3.8 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 7 | -12.3 | 7.6 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -11.2 | -76.7 | 3.8 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 4.6 | 4.3 | 3.8 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 15.2 | 2.7 | 23.2 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | -63 | -116.2 | -67.5 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -74.2 | -192.9 | -63.7 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 0.5 | -2.8 | -4.4 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | -74.7 | -190.1 | -59.2 |
Häufig gestellte Frage
Wie hoch ist die Standard BioTools Inc. (LAB) Gesamtvermögen?
Standard BioTools Inc. (LAB) Gesamtvermögen ist 323067000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.472.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -0.578.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -0.702.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -0.659.
Was ist der Standard BioTools Inc. (LAB) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -74656000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 98210000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 113489000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.